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Abstract
Background: Viral hepatitis is a life-threatening liver disease that has become important public health issue in
developing countries including Ethiopia. This study was undertaken to determine the seroprevalence of HBsAgs
and anti-HCV antibodies and what socio-demographic factors are associated with sero-positivity of Hepatitis B Virus
(HBV) and Hepatitis C Virus (HCV) infections among pregnant women attending maternity ward of Felege Hiwot
Referral Hospital, northwest, Ethiopia.
Methods: Hospital based cross-sectional study was conducted from November 2013 to January 2014. Blood samples
were randomly collected from 384 pregnant women. Data on socio-demographic characteristics, obstetric and
potential risk factors were collected using semi-structured questionnaire. Chromatographic kits were used to detect
the presence of HBsAg and antibodies against HCV in serum samples of the studied subjects. Chi-square test was
used for assessing the association between socio-demographic variables and HBV and HCV status. Logistic regression
analysis was done to determine the strength of association between risk factors and HBV or HCV infection. P-values
less than 0.05 were considered as significant.
Results: Seroprevalnce of hepatitis B and C virus infections were found to be 4.4 and 0.26 %, respectively. None of
the pregnant women were co-infected by these two viruses. Amongst the potential risk factors, previous history of
dental procedure (AOR = 4.104, CI = 1.276–13.201, P = 0.018), house hold contact (AOR = 5.475, CI = 1.472–20.368,
P = 0.011), multiple sexual exposure (AOR = 5.041, CI = 1.580–16.076, P = 0.006), and delivery at traditional birth
attendants (AOR = 4.100, CI = 0.195-86.129, P = 0.024) were significantly associated with and important predictors of
hepatitis B infection.
Conclusions: This study found an intermediate endemicity (4.4 %) of HBV infection in pregnant women whereas
seroprevalence of anti-HCV antibody was very small, but this needs to be confirmed by other similar studies with
larger sample size. Thus, scaling up of the screening of pregnant women for HBV and HCV infections and provision of
health education about the risk factors, the mode of transmissions and prevention is recommended.
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Introduction
Hepatitis is the inflammation of liver, most commonly
caused by viral infections. Five hepatotropic viruses (A
to E) are known to cause hepatitis. Of these, hepatitis B
virus (HBV) and hepatitis C virus (HCV) are of greater
importance and among the most frequent viral infec-
tions in humans [1, 2]. Globally, there are about 240
million people with chronic HBV infection and 130 to
150 million people with chronic HCV infection, reaching
endemic proportions in sub Saharan Africa. HBV is esti-
mated to result in 780,000 deaths and HCV in 350,000
to 500,000 deaths annually [3, 4].
HBV is highly contagious and relatively easy to be
transmitted from one infected individual to another by
blood to blood contact, during birth, unprotected sex,
and by sharing needles while, HCV is transmitted mainly
by parenteral routes such as intravenous drug use or
blood product transfusion, transmission during sexual
contact or during delivery is also possible, but is much
less common [3, 4].
Chronic infection with HBV and HCV are often asymp-
tomatic, but can lead to liver cirrhosis and hepatocellular
carcinoma. Thus, most infected people are unaware of
their HBV or HCV statuses until significant liver damage
has occurred. Severe liver diseases are more frequent
when patients are coinfected by the two viruses [5].
Combined HBV/HCV infection is sometimes observed
because of the overlap in transmission routes of these
viruses [6].
Viral hepatitis during pregnancy is associated with
high risk of maternal, fetal and neonatal complications.
There is a high rate of vertical transmission of HBV
causing fetal and neonatal hepatitis, which may lead to
impaired mental and physical health later in life [7].
Neonatal hepatitis can lead to chronic virus carriage,
which in turn may lead to liver cirrhosis and hepatocel-
lular carcinoma in young adults [7, 8]. Apart from this,
acute hepatitis in pregnancy has been shown to induce
premature labor and prematurity with its attendant
effects [9, 10].
Incidence of hepatitis varies greatly around the world.
In developed countries, the incidence is around 0.1 %
whereas in developing countries it can range from 3 to
20 % or higher. There is no difference in the course of
the disease in pregnant and non-pregnant women in
developed countries. However, in developing countries,
there is a higher incidence of maternal mortality with
fulminant hepatitis [11]. This difference may be attribut-
able to the variation in population studied, genetic factors,
socioeconomic status, cultural practices and regional dif-
ferences in risk factors to viral hepatitis [12].
HBV and HCV infections are the major global public
health problems spreading rapidly in the developing
countries including Ethiopia. Hence, screening antenatal
women for hepatitis B surface antigen and anti HCV
antibodies can give a reliable prevalence of the disease in
a population and provide an avenue for preventing
mother to child transmission of the virus. To the best of
our knowledge, an epidemiological report of this type is
sparse and quite inadequate in the country. Thus, the
current study was aimed at investigating the seropreva-
lence and the possible risk factors of HBV and HCV
among pregnant women attending maternal care Bahir
Dar, Felege Hiwot Referral Hospital, northwest, Ethiopia.
Materials and methods
Study design and period
A hospital based cross sectional study was conducted
from November 2013 to January 2014 so as to determine
seroprevalence of HBsAgs and anti HCV antibodies and
associated risk factors among pregnant women attending
antenatal care center of Felege Hiwot Referral Hospital,
Bahir Dar, Ethiopia.
Source and study population
All pregnant women attending antenatal care center of
Felege Hiwot Referral Hospital were considered as a
source population while, those who visited the antenatal
care center of the hospital during sample collection period
were considered as a study population.
Inclusion and exclusion criteria
Pregnant women who were willing to participate and
provide consent were included in the study. Those who
were already positive for hepatitis B and C and who did
not consent to the study were excluded.
Study variables
Dependent variables
In this study, two dependent variables, serostatus of hepa-
titis B and C viruses of respondents were studied.
Independent variables
Socio-demographic characteristics like, age, residence,
educational, occupational status, income and marital
status and clinical factors like parity status and gesta-
tional age were studied. History of blood transfusion,
history of abortion, surgical procedure, dental surgery,
tattooing, unsafe injection, history of house hold contact,
multiple sexual exposure, use of condom and mode of
delivery were also examined as possible risk factors for
HBV and HCV.
Sampling technique and sample size estimation
The study participants were selected by simple random
sampling method based on the random accessibility of the
patient during the study period until the required sample
size was obtained. In the estimation of the sample size,
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statistical formula for sample size calculation was consid-
ered as a basis [13]. As prevalence of these infectious
diseases is not known in the study area, the sample size of
the proposed study was calculated using 50 % prevalence
and a minimum sample size of 384 was obtained and





Where n = sample size
d =margin of error (5 %)
P = prevalence (50 %)
z = critical value at 5 % level (1.96)
Data collection and processing
Socio-demographic characteristics and potential risk factors
Study participants who fulfilled eligibility criteria were
interviewed by the nurses to gather relevant information
using pre-designed questionnaire. The questionnaire in-
cluded socio-demographic characteristics like age, resi-
dential area, and level of education, occupation, income,
marital status, parity status and gestational age. Data on
potential risk factors like history of dental and surgical
procedure, tattooing, exposures to unsafe injection, his-
tory of delivery at traditional birth attendants, abortion,
and history of house hold contact, blood transfusion and
ear piercing in jewelers shop were also obtained.
Blood sample collection and processing
Five milliliters of venous blood were collected by medical
laboratory technicians and the blood samples were left for
30 min to facilitate clotting. Then the clotted blood sam-
ples were centrifuged to separate the serum from blood
cells. The serum was divided in two aliquots: one for
HBsAg and the other for Anti-HCV antibody screening.
Serological detection of hepatitis B surface antigen and
Anti-HCV test
Advanced Quality One Step HBsAg test strip was used
for the detection of hepatitis B surface antigen (HBsAg)
following the instructions of the manufacturer (Intec
Products, Inc. (Xiamen), China). For the detection of
antibodies produced against HCV dBest one Step HCV
test strip was used following the instructions of the manu-
facturer (Ameritech Diagnostic Reagent Co, Tongxiang,
Zhejiang, China). The sensitivity and specificity of the
HBV test were 98.89 and 98.87 % respectively, whereas for
the anti-HCV test they were 93.3 and 99.5 % respectively.
Data analysis and interpretation
The prevalence of each viral infection (HBV and HCV)
was determined from the proportion of the positive indi-
viduals in the total population under consideration and
expressed as a percentage. The collected data were
entered and analyzed using SPSS statistical software
(version 20.0). They were organized and summarized in
terms of frequencies and the results of the study were
presented in tables. The chi-square (χ2) test was utilized
for assessing statistical significance of association that
could exist between socio-demographic variables and
HBV and HCV status and p-values less than 0.05 were
considered as significant. Logistic regression analysis was
done to determine the strength of association between
risk factors and HBV or HCV infection.
Ethical considerations
Ethical clearance was obtained from ethical review board
of Bahir Dar University. After explaining the objective of
the study, first verbal informed consent and then written
consent was obtained from each of the study participants
to gather blood samples and data on sociodemographics.
Subjects positive for HBsAg and anti-HVC antibody were
reported to physicians for possible follow up and treat-
ment. All information collected during the study was kept
confidential.
Results
Socio demographic and clinical data of study participants
A total of 384 pregnant women were included in this
study from November 2013 to January 2014. The mean
age of the study subjects was 26.96 years (SD ± 4.58)
with majority of the women falling in the age category of
25 to 29 years. This age category constituted 45.8 % of
the total pregnant women and the lowest number of
pregnant women was in15–19 years (1.3 %). Majority of
the subjects were married (93.2 %) followed by single
(5.5 %) and separated (1.3 %). Of participants, 43 (11.2 %)
did not attend formal education while 103 (26.8 %) could
read and write. Among the 384 pregnant women, 340
(88.5 %) were urban residents and 44 (11.5 %) were from
rural settings (Table 1).
HBV and HCV seroprevalence and socio- demographic
and clinical characteristics
In this study, about 18 pregnant women (4.7 %) had
serological evidence of infection with viral hepatitis, of
these, the seroprevalence of HBsAg and anti HCV anti-
body was 4.4 and 0.26 %, respectively (Table 2) and while
no co-infected pregnant women were detected.
Association of HBsAg sero-positivity and
socio-demographic characteristics
HBsAg sero-positivity was detected in most of age cat-
egories except for 15–19 and 35–39 years old. The
highest age-specific prevalence was identified in the age
group 40–44. Out of seven women screened in this age
category, 14.3 % tested positive for HBsAg. There was
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no statistically significant association between distribu-
tion of HBsAg and the age categories (P = 0.23). Majority
of the study participants (93.2 %) were married, of which
4.2 % were positive for HBsAg. From 21 single pregnant
women two (9.5 %) were positive for HBsAg and none
of the separated women tested positive for HBsAg.
There was no statistically significant association between
HBsAg and the marital status of the study subjects (P =
0.456). The prevalence of HBV infection in relation to
residence revealed that of the total 340 urban and 44
rural dwellers, 4.7 and 2.3 %, respectively, tested positive
for HBsAg. However, no statistically significant associ-
ation was detected between seroprevalence of HBsAg
and residence (P = 0.477) (Table 3).
Occupation wise, the highest (9.1 %) frequency of HBV
infection was observed among women who are involved
in different activities followed by those who are privately
employed (6.0 %). In this study, no statistically significant
association was observed between HBsAg positivity and
occupation of the study subjects (P = 0.58). Relatively,
similar rates of serological evidence of HBsAg were de-
tected among most educational categories except for those
who are illiterate (2.3 %). However, there is no statistically
significant association between HBsAg distribution and
educational status (P = 0.811). The highest seroprevalence
(6.8 %) of HBsAg was among women who earn the lowest
monthly income (<500 Ethiopian birr/month). But, no
statistically significant association was observed between
seroprevalence of HBsAg and monthly income (P = 0.345).
The prevalence of HBV infection among women who
were pregnant for the first time was 2.4 %, while it was
5.1 % among the gravidae II and 7.1 % among multi-
gravidae. However, no statistically significant relation was
detected between HBsAg distribution and parity status of
study subjects (P = 0.184). 7.4 and 3.3 % of pregnant
women in their second and third trimester respectively
tested positive for HBsAg, whereas, none of those in the
first trimester infected with HBV. However, occurrence of
HBsAg and gestational age was not statistically significant
(P = 0.077) (Table 3).
Potential risk factors of HBV and HCV among the study
subjects
Associations between HBV infection and risk factors were
analyzed using logistic regression. Multivariate logistic
regression analysis was used for controlling confounders
and for evaluating the strength of association of risk
variables with HBV infection among studied group. The
variables (dental extraction, history of delivery by the help
of traditional birth attendants, history of household con-
tact and history of multiple sexual exposures) were found
to be associated with HBV infection in the univariate
analysis were entered into the multivariate logistic regres-
sion model. In the final model, the same four variables
were found to be significant predictors of HBV infection
(p < 0.05) (Table 4).
In relation to dental extraction, 29.2 % of the study
subjects responded that they had previous history dental
extraction, of which, 9.7 % were found to be positive for
HBsAg. Statistically significant association was observed
between previous history dental extraction and HBV
infection (P = 0.018). Those who had dental extraction
Table 1 Socio demographic characteristics of the study
participants
Parameter Frequency Percent
n = 384 (%)






Marital status Married 358 93.2
Single 21 5.5
Separated 5 1.3
Residential area Urban 340 88.5
Rural 44 11.5
Educational Status Illiterate 43 11.2
Read and write 103 26.8
Secondary school 116 30.2
College and above 122 31.8
Occupation Daily laborer 17 4.4
House wife 162 42.2
Privately employed 83 21.6
Gov’t employee 111 28.9
Other 11 3.4
Monthly income (Birr) <500 74 19.3
500–1000 88 21.6
>1000 222 59.1
Table 2 Seroprevalence of hepatitis B and C infections among
the study subjects
Variables Status Total (%)
HBsAg Positive 17 (4.4)
Negative 367 (95.6)
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were 4.034 times more likely to have infection with
HBV than their counterparts (AOR = 4.104, 95 % CI =
1.276–13.201).
Pregnant women who had previous history of house
hold contact were 6.3 %, of which 20 % were positive for
HBsAg. Statistically significant association was detected
between having previous contact with members of the
house hold with HBV infection (P = 0.011). Pregnant
women who had previous history of house hold contact
were 5.451 times more likely to have infection with HBV
than those without previous history of house hold
contact (AOR = 5.475, 95 % CI = 1.472–20.368).
The proportion of study participants who had mul-
tiple sexual partners was 32.8 %, of which 9.5 % were
positive for HBsAg. Statistically significant association
was detected between HBV infection and having mul-
tiple sexual partner (p = 0.006). Women having history
of multiple sexual partner were 5.168 times at elevated risk
of contracting HBV infection (AOR = 5.041, 95 % CI =
1.580–16.076) (Table 4).
Among 384 pregnant women, 167 had a history of
delivering at home by traditional birth attendants, of
these, 7.2 % were positive for HBsAg. Statistically signifi-
cant association was obtained between these variables
(p = 0.024). Those pregnant women with history of home
delivery by traditional birth attendants were 4.100 times
more likely to have HBV infection (AOR = 4.100, 95 %
CI = 0.195–86.129).
Table 3 Seroprevalence of HBsAg in relation to socio demographic characteristics
Parameter Level HBV status Df Chi-square p-value
Negative Positive
Count Percentage Count Percentage
Age (years) 15–19 5 100.0 0 0.0
20–24 106 98.1 2 1.9
25–29 167 94.6 9 5.1
30–34 56 91.9 5 8.1 5 6.872 0.23
35–39 27 100.0 0 0.0
40–44 6 85.7 1 14.3
Marital status Married 343 95.8 15 4.2 2 1.568 0.456
Single 19 90.5 2 9.5
Separated 5 100.0 0 0.0
Residential area Urban 324 95.3 16 4.7 1 0.505 0.477
Rural 43 97.3 1 2.3
Educational status Illiterate 42 97.7 1 2.3 3 0.96 0.811
Read and write 97 94.2 6 5.8
Secondary school 111 95.7 5 4.3
College and above 117 95.9 5 4.1
Occupation Daily laborer 16 94.1 1 5.9
House wife 158 97.5 4 2.5 4 2.87 0.58
Privately employee 78 94.0 5 6.0
Gov’t employee 105 94.6 6 5.4
Others 10 90.9 1 9.1
Monthly income <500 69 93.2 5 6.8
500–100 83 94.3 5 5.7 2 2.128 0.345
>1000 215 96.8 7 3.2
Parity status Primigravidae 163 97.6 4 2.4 2 3.385 0.184
Gravidae two 112 94.9 6 5.1
Multigravidae 92 92.9 7 7.1
Gestational Age First trimester 39 100.0 0 0.0
2nd trimester 126 92.6 10 7.4 2 5.13 0.077
3rd trimester 202 96.7 7 3.3
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Discussion
HBV and HCV infections are significant health problems
around the globe. Both infections are associated with a
broad range of clinical presentations ranging from acute
hepatitis to chronic infection that may be clinically
asymptomatic or may progress to chronic hepatitis and
liver cirrhosis [3, 4]. HBV infection affecting pregnant
women may result in severe disease to the mother and
chronic infection to the newborn [8]. The long term
morbidity and mortality of HCV is far greater than HBV
[14]. It has been reported that infants born to women
with hepatitis C infection to be at risk of poor birth out-
comes, including preterm birth, low birth weight, and
congenital anomaly [15].
In the present study, sera collected from pregnant
women were screened for HBsAg and anti-HCV. HBsAg
detection serves as a marker for active HBV infection
and infectivity whereas anti-HCV is a marker that shows
someone has been exposed to HCV previously. The sero-
prevalence of hepatitis B and hepatitis C viral infections
among the present study participants was 4.4 and 0.26 %,
respectively. HBsAg is the main marker indicating preva-
lence as well as endemicity of HBV infection in the
general population of particular geographical area [16].
On the basis of the carrier rate of this maker, WHO cate-
gorized countries of the world in to 3 regions of high
(>8 %), medium (2–7 %) and low endemicity (<2 %) [17].
The 4.4 % prevalence of HBsAg observed in the present
study area appears to be an intermediate endemicity
according to WHO criteria of global epidemiology of
HBV infection [17, 18].
The seroprevalence of hepatitis B surface antigen in
this study is in concordance with the study carried out
in Dar es Salaam, Tanzania 3.9 % [19], in Egypt 4.0 %
Table 4 Association of potential risk factors and hepatitis B virus infection among study subjects
Variables HBV status COR(CI) AOR(CI) P-value
Positive N (%) Negative N (%)
History of abortion
Yes 4(4.3) 91(95.7) 0.933(0.297–2.934) 0.528(0.135–2.06) 0.358
No 13(4.5) 276(95.5) 1 1
Surgical operation
Yes 1(2.2) 45(97.8) 0.447(0.058–3.454) 0.367(0.035–3.822) 0.402
No 16(4.7) 322(95.3) 1 1
Blood transfusion
Yes 1(11.1) 8(89.9) 2.805(0.331–23.798) 2.136(0.177–25.735) 0.550
No 16(4.3) 359(95.7) 1
Ear piercing
Yes 10(4.6) 207(95.4) 1.097(0.409–2.946) 0.532(0.171–1.657) 0.276
No 7(4.2) 160(95.8) 1 1
Exposure to unsafe injection
Yes 3(8.1) 34(91.9) 2.099(0.574–7.67) 3.288(0.727–14.875) 0.122
No 14(4.0) 333(96.0) 1 1
Dental extraction
Yes 11(9.7) 102(90..3) 4.763(1.376–10.014) 4.104(1.276–13.201) 0.018*
No 6(2.2) 265(97.8) 1 1
History of house hold contact
Yes 5(20) 20(80.0) 7.229(2.320–22.524) 5.475(1.472–20.368) 0.011*
No 12(3.3) 347(96.7) 1 1
History of multiple sexual exposure
Yes 12(9.5) 114(90.5) 5.326(1.833–15.473) 5.041(1.580–16.076) 0.006*
No 5(1.9) 253(98.1) 1 1
Delivery by traditional birth attendants
Yes 12(7.2) 155(92.8) 3.794(0.481–29.917) 4.100(0.195–86.129) 0.024*
No 1(2.0) 49(98.0) 1 1
Key: COR crude odd ratio, AOR adjusted odd ratio
*p-value <0.05, 1 = reference value
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[20] and in Port Harcourt, South Nigeria 4.3 % [21].
Furthermore, the present result is in line with the findings
of similar studies from two Asian countries, Saudi Arabia
(4.1 %) [22] and Pakistan (4.6 %) [23]. However, the preva-
lence of HBsAg in this study is lower than prevalence
rates of 7.9, 9.3 and 10.2 % reported among similar ante-
natal clinic attendees in Kano, Nigeria [24], in Kenya [25]
and in Far North Region of Cameroon [26], respectively.
Likewise, it was also lower compared to recent similar
studies reported from different parts of the world [27–29].
In contrast, HBsAg seroprevalence in this study is rela-
tively higher than the findings of studies from 0.61 % India
[30], 1.5 % Libya [31], 1.53 % Afghanistan [32] and 1.65 %
Mexico [33]. Differences in demographics, cultural prac-
tices and behavior of the study population for the risk of
HBV infection might explain these discrepancies.
The seroprevalence of anti-HCV antibody in the present
study was found to be 0.26 % (1/384). This result was
nearly similar with a study conducted in Nigeria 0.6 %
[34]. In contrast, the finding in this study was much lower
than anti HCV antibody seroprevalence rates of 3.6 and
8.5 % demonstrated in Nigeria [27] and Yemen [28],
respectively. The lower prevalence of anti HCV antibody
in the current study might be due to the difference in
habit of using intravenous drug, exposure to blood trans-
fusion, difference in efficiency of diagnostic kits used.
Comparable studies from different countries have docu-
mented coinfection of HBV and HCV [12, 27], however,
no coinfection of these viral infections were detected in
our study, which is in line with the findings of Murad
et al. [28] and Oladeinde et al. [35].
In the present study, socio-demographic variables like
age, marital and educational status, residence and occu-
pations of participants as well as reproductive variables
like gravidity and parity were not significantly associated
with the risk of HBV infection (P > 0.05). This result is
consistent with the reports by Rabiu et al. [36] and
Oladeinde et al. [37]. However, it is difficult to rule out
the associations of these variables totally with HBV
infection.
In multivariate analysis, history of delivery by a traditional
birth attendant (TBA) was found to be significantly associ-
ated with HBV infection (P = 0.024). Pregnant women
who delivered by TBAs were 4.100 times more likely to
have HBV infection. This is in agreement with a report
from Nigeria [35]. Repeated use of old and unsterilized
instruments during delivery by uneducated and unskilled
birth attendants may account for this observation [38].
Therefore, it is plausible to suggest that engagement in
these activities could have exposed pregnant women to
HBV infection.
It has been reported that HBV can be transmitted
between family members within a household through
sharing personal items such as, tooth brushes and
shaving razors with an infected person and exposure to
blood from needle sticks or other sharp instruments
contaminated with HBsAg of chronically infected persons
[39, 40]. In our study, statistically significant association
was observed between subjects who had history of contact
with HBV infected family member and HBV infection
(p = 0.011). Pregnant women who had contact with HBV
infected person in their household were 5.451 times more
likely to be HBsAg seropositive. The habit of sharing vari-
ous personal and household articles within the home, as
demonstrated in this study, provided an important mech-
anism for the transfer of HBV from asymptomatic carriers
to other family members [41].
Furthermore, dental treatment was found to be a
potential risk factor for HBV infection in our study and
pregnant women who had history of dental treatment
were at 4.034 times increased risk of HBV infection.
This finding is consistent with previous serologic data of
pregnant women from Jimma, Ethiopia [42]. Likewise,
Pande et al. [43] also evidenced that history of dental
treatment was a risk factor for HBV infection. This might
be due to non adherence to guidelines on infection con-
trol and use of non disposable or reusable equipments
and the lack of sufficient sterilization technology.
Sexual transmission has long been recognized as a
major source of HBV transmission in the world [44]. It
is, therefore, not surprising to identify multiple sexual
exposures as significant risk factor for HBsAg seroposi-
tivity. In the current study, statistically significant associ-
ation was observed between history of multiple sexual
exposure and HBV infection (P < 0.05). Individuals who
had multiple sexual partners were at five fold of elevated
risk of acquiring HBV infection. This is in agreement
with the findings of Rabiu et al. [36] and Obi et al. [45],
who also demonstrated a history of multiple sexual part-
ners to be significant risk factors for HBV infection
during pregnancy. Changes in sexual practice and behav-
ior modification may therefore be an important step
towards reduction of hepatitis B infection.
Conclusions
An intermediate and low prevalence rates of HBsAg
and anti HCV antibodies respectively, were detected
in this study. However, no co-infection of these hepa-
totropic viruses was obtained. No statistically signifi-
cant association was observed in acquisition of HBV
infection and socio-demographics and variables like
parity and gestational age. Previous history of dental
treatment, household contact, delivery at traditional
birth attendant and multiple sexual exposures were
found to be important indicators of HBV infection in
this study. There should be routine screening of all
pregnant women for hepatitis B and C virus infections for
possible early immunization of infants of seropositive
Molla et al. Virology Journal  (2015) 12:204 Page 7 of 9
mothers. Molecular characterization and detection of the
other markers should be conducted to determine the
exact prevalence of HBV and HCV in future study.
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